{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:11:31Z","timestamp":1787062291313,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Brain metastasis (BM) frequently occurs in advanced non-small cell lung cancer (NSCLC) and is associated with poor clinical prognosis. Due to the location of metastatic lesions, the surgical resection is limited and the chemotherapy is ineffective because of the existence of the blood brain barrier (BBB). Therefore, it is essential to enhance our understanding about the underlying mechanisms associated with brain metastasis in NSCLC. In the present study, we explored the RNA-Seq data of brain metastasis cells from the GEO database, and extracted RNA collected from primary NSCLC tumors as well as paired brain metastatic lesions followed by microRNA PCR array. Meanwhile, we improved the in vivo model and constructed a cancer stem cell-derived transplantation model of brain metastasis in mice. Our data indicated that the level of miR-596-3p is high in primary NSCLC tumors, but significantly downregulated in the brain metastatic lesion. The prediction target of microRNA suggested that miR-596-3p was considered to modulate two genes essential in the brain invasion process, YAP1 and IL-8 that restrain the invasion of cancer cells and permeability of BBB, respectively. Moreover, in vivo experiments suggested that our model mimics the clinical aspect of NSCLC and improves the success ratio of brain metastasis model. The results demonstrated that miR-596-3p significantly inhibited the capacity of NSCLC cells to metastasize to the brain. Furthermore, these finding elucidated that miR-596-3p exerts a critical role in brain metastasis of NSCLC by modulating the YAP1-IL8 network, and this miRNA axis may provide a potential therapeutic strategy for brain metastasis.<\/jats:p>","DOI":"10.1038\/s41419-022-05062-7","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T02:03:36Z","timestamp":1660269816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1822-928X","authenticated-orcid":false,"given":"Chenlong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7108-3574","authenticated-orcid":false,"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"5062_CR1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1634\/theoncologist.12-7-884","volume":"12","author":"AF Eichler","year":"2007","unstructured":"Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist. 2007;12:884\u201398.","journal-title":"Oncologist"},{"key":"5062_CR2","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00415-002-0870-6","volume":"249","author":"R Soffetti","year":"2002","unstructured":"Soffetti R, Ruda R, Mutani R. Management of brain metastases. J Neurol. 2002;249:1357\u201369.","journal-title":"J Neurol"},{"key":"5062_CR3","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.10541","volume":"94","author":"LJ Schouten","year":"2002","unstructured":"Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94:2698\u2013705.","journal-title":"Cancer."},{"key":"5062_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","volume":"22","author":"N Hanna","year":"2004","unstructured":"Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004;22:1589\u201397.","journal-title":"J Clin Oncol"},{"key":"5062_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-6-23","volume":"6","author":"S Villa","year":"2011","unstructured":"Villa S, Weber DC, Moretones C, Manes A, Combescure C, Jove J, et al. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study. Radiat Oncol. 2011;6:1\u20138.","journal-title":"Radiat Oncol"},{"key":"5062_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11060-017-2590-x","volume":"135","author":"M Ge","year":"2017","unstructured":"Ge M, Zhuang Y, Zhou X, Huang R, Liang X, Zhan Q. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases. J Neurooncol. 2017;135:413\u20138.","journal-title":"J Neurooncol"},{"key":"5062_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc3053","volume":"11","author":"PS Steeg","year":"2011","unstructured":"Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011;11:352\u201363.","journal-title":"Nat Rev Cancer"},{"key":"5062_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1517\/14656561003702412","volume":"11","author":"C Arslan","year":"2010","unstructured":"Arslan C, Dizdar O, Altundag K. Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother. 2010;11:1089\u20131100.","journal-title":"Expert Opin Pharmacother"},{"key":"5062_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/JN.S148107","volume":"5","author":"J Xiao","year":"2017","unstructured":"Xiao J, Chen L, Mao GS, Gao WY, Lu M, He XJ, et al. Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells. J Neurorestoratology. 2017;5:175\u20139.","journal-title":"J Neurorestoratology"},{"key":"5062_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.semcancer.2010.12.009","volume":"21","author":"IJ Fidler","year":"2011","unstructured":"Fidler IJ. The role of the organ microenvironment in brain metastasis. Semin Cancer Biol. 2011;21:107\u201312.","journal-title":"Semin Cancer Biol"},{"key":"5062_CR11","doi-asserted-by":"publisher","first-page":"26641","DOI":"10.1074\/jbc.R700023200","volume":"282","author":"B Berkhout","year":"2007","unstructured":"Berkhout B, Jeang KT. RISCy business: microRNAs, pathogenesis, and viruses. J Biol Chem. 2007;282:26641\u20135.","journal-title":"J Biol Chem"},{"key":"5062_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","volume":"13","author":"SL Yu","year":"2008","unstructured":"Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13:48\u201357.","journal-title":"Cancer Cell"},{"key":"5062_CR13","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5062_CR14","doi-asserted-by":"publisher","first-page":"e1007888","DOI":"10.1371\/journal.pgen.1007888","volume":"2","author":"G Sun","year":"2019","unstructured":"Sun G, Ding X, Bi N, Wang Z, Wu L, Zhou W, et al. Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma. PLoS Genet. 2019;2:e1007888.","journal-title":"PLoS Genet"},{"key":"5062_CR15","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.18632\/aging.102201","volume":"17","author":"C Wei","year":"2019","unstructured":"Wei C, Zhang R, Cai Q, Gao X, Tong F, Dong J, et al. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer. Aging 2019;17:6734\u201361.","journal-title":"Aging"},{"key":"5062_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0955-5","volume":"10","author":"G Sun","year":"2018","unstructured":"Sun G, Ding X, Bi N, Wu L, Wang J, Zhang W, et al. MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology. Cell Death Dis. 2018;10:936.","journal-title":"Cell Death Dis"},{"key":"5062_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12094-015-1347-2","volume":"2","author":"J Remon","year":"2016","unstructured":"Remon J, Alvarez-Berdugo D, Majem M, Moran T, Reguart N, Lianes P. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers. Clin Transl Oncol. 2016;2:153\u20139.","journal-title":"Clin Transl Oncol"},{"key":"5062_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nprot.2008.14","volume":"3","author":"CG Liu","year":"2008","unstructured":"Liu CG, Calin GA, Volinia S, Croce CM. MicroRNA expression profiling using microarrays. Nat Protoc. 2008;3:563\u201378.","journal-title":"Nat Protoc"},{"key":"5062_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00109-012-0971-3","volume":"91","author":"R McDermott","year":"2013","unstructured":"McDermott R, Gabikian P, Sarvaiya P, Ulasov I, Lesniak MS. MicroRNAs in brain metastases: big things come in small packages. J Mol Med. 2013;91:5\u201313.","journal-title":"J Mol Med"},{"key":"5062_CR20","doi-asserted-by":"publisher","first-page":"10508","DOI":"10.3390\/ijms150610508","volume":"15","author":"S Alsidawi","year":"2014","unstructured":"Alsidawi S, Malek E, Driscoll JJ. MicroRNAs in brain metastases: potential role as diagnostics and therapeutics. Int J Mol Sci. 2014;15:10508\u201326.","journal-title":"Int J Mol Sci"},{"key":"5062_CR21","first-page":"192","volume":"21","author":"G D\u2019Addario","year":"2010","unstructured":"D\u2019Addario G, Fruh M, Reck M, Baumann P, Klepetko W, Felip E, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:192\u2013237.","journal-title":"Ann Oncol"},{"key":"5062_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009;459:1005\u20139.","journal-title":"Nature"},{"key":"5062_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-6730-8_8","volume":"1546","author":"SF Hawkins","year":"2017","unstructured":"Hawkins SF, Guest PC. Multiplex analyses using real-time quantitative PCR. Methods Mol Biol. 2017;1546:125\u201333.","journal-title":"Methods Mol Biol"},{"key":"5062_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cell.2009.04.030","volume":"138","author":"DX Nguyen","year":"2009","unstructured":"Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, et al. WNT\/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009;138:51\u201362.","journal-title":"Cell"},{"key":"5062_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/jnci\/djt022","volume":"105","author":"SM Nolte","year":"2013","unstructured":"Nolte SM, Venugopal C, McFarlane N, Morozova O, Hallett RM, O\u2019Farrell E, et al. A cancer stem cell model for studying brain metastases from primary lung cancer. J Natl Cancer Inst. 2013;105:551\u201362.","journal-title":"J Natl Cancer Inst"},{"key":"5062_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7716","volume":"6","author":"N Tominaga","year":"2015","unstructured":"Tominaga N, Kosaka N, Ono M, Katsuda T, Yoshioka Y, Tamura K, et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood\u2013brain barrier. Nat Commun. 2015;6:6716.","journal-title":"Nat Commun"},{"key":"5062_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"1","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate-A practical and powerful approach to multiple testing. J R Stat Soc. 1995;1:289\u2013300.","journal-title":"J R Stat Soc"},{"key":"5062_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/039463201202500304","volume":"25","author":"J Zhang","year":"2012","unstructured":"Zhang J, Xu ZP, Yang YC, Zhu JS, Zhou Z, Chen WX. Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis. Int J Immunopathol Pharm. 2012;25:583.","journal-title":"Int J Immunopathol Pharm"},{"key":"5062_CR29","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.1992.263.1.C1","volume":"263","author":"EN Benveniste","year":"1992","unstructured":"Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol. 1992;263:C1\u2013C16.","journal-title":"Am J Physiol"},{"key":"5062_CR30","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1038\/sj.bjp.0706400","volume":"147","author":"SM D. Lucas","year":"2006","unstructured":"D. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharm. 2006;147:S232\u2013S240.","journal-title":"Br J Pharm"},{"key":"5062_CR31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1099\/0022-1317-50-9-812","volume":"50","author":"N E.Tsao","year":"2001","unstructured":"E.Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol. 2001;50:812\u201321.","journal-title":"J Med Microbiol"},{"key":"5062_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","volume":"137","author":"S Valastyan","year":"2009","unstructured":"Valastyan S, Reinhardt F, Benaich N, Calogrias D, Sz\u00e1sz AM, Wang ZC, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009;137:1032\u201346.","journal-title":"Cell"},{"key":"5062_CR33","first-page":"558","volume":"40","author":"SL Wood","year":"2014","unstructured":"Wood SL, Pernemalm M, Crosbie PA, Whetton AD. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer\u2002Treat Rev. 2014;40:558\u201366.","journal-title":"Cancer\u2002Treat Rev"},{"key":"5062_CR34","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.4103\/2152-7806.111303","volume":"4","author":"R Ramakrishna","year":"2013","unstructured":"Ramakrishna R, Rostomily R. Seed, soil, and beyond: the basic biology of brain metastasis. Surg Neurol Int. 2013;4:S256\u2013S264.","journal-title":"Surg Neurol Int"},{"key":"5062_CR35","doi-asserted-by":"publisher","first-page":"27461","DOI":"10.18632\/oncotarget.4742","volume":"6","author":"M Singh","year":"2015","unstructured":"Singh M, Garg N, Venugopal C, Hallett R, Tokar T, McFarlane N, et al. STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation. Oncotarget 2015;6:27461\u201377.","journal-title":"Oncotarget"},{"key":"5062_CR36","doi-asserted-by":"publisher","first-page":"20434","DOI":"10.18632\/oncotarget.3886","volume":"6","author":"SJ Hwang","year":"2015","unstructured":"Hwang SJ, Lee HW, Kim HR, Song HJ, Lee DH, Lee H, et al. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1. Oncotarget. 2015;6:20434\u201348.","journal-title":"Oncotarget"},{"key":"5062_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro A, Panciera T, Piccolo S. YAP\/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20:888\u201399.","journal-title":"Nat Cell Biol"},{"key":"5062_CR38","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.celrep.2017.04.075","volume":"19","author":"Y Qiao","year":"2017","unstructured":"Qiao Y, Chen J, Lim YB, Finch-Edmondson ML, Seshachalam VP, Qin L, et al. YAP regulates actin dynamics through ARHGAP29 and promotes metastasis. Cell Rep. 2017;19:1495\u2013502.","journal-title":"Cell Rep"},{"key":"5062_CR39","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrc1370","volume":"4","author":"K Pantel","year":"2004","unstructured":"Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4:448\u201356.","journal-title":"Nat Rev Cancer"},{"key":"5062_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ijc.27324","volume":"131","author":"S Izraely","year":"2012","unstructured":"Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M, et al. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer. 2012;131:1071\u201382.","journal-title":"Int J Cancer"},{"key":"5062_CR41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.7150\/ijbs.6996","volume":"9","author":"H Yu","year":"2013","unstructured":"Yu H, Huang X, Ma Y, Gao M, Wang O, Gao T, et al. Interleukin-8 regulates endothelial permeability by down-regulation of tight Junction but not dependent on integrins induced focal adhesions. Int J Biol Sci 2013;9:966\u201379.","journal-title":"Int J Biol Sci"},{"key":"5062_CR42","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/jovr.jovr_110_17","volume":"13","author":"D Ganatra","year":"2018","unstructured":"Ganatra D, Vasavada A, Vidya N, Gajjar D, Rajkumar S. Trichostatin A restores expression of adherens and tight junction proteins during transforming growth factor \u03b2-mediated epithelial-to-mesenchymal transition. J Ophthalmic Vis Res. 2018;13:274\u201383.","journal-title":"J Ophthalmic Vis Res"},{"key":"5062_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/MEG.0b013e3283470212","volume":"23","author":"W Wang","year":"2011","unstructured":"Wang W, Lv S, Zhou Y, Fu J, Li C, Liu P. Tumor necrosis factor-alpha affects blood-brain barrier permeability in acetaminophen-induced acute liver failure. Eur J Gastroenterol Hepatol. 2011;23:552\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5062_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0169-328X(99)00007-8","volume":"69","author":"GY Yang","year":"1999","unstructured":"Yang GY, Gong C, Qin Z, Liu XH, Lorris Betz A. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res. 1999;69:135\u201343.","journal-title":"Brain Res Mol Brain Res"},{"key":"5062_CR45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0024-3205(95)00008-T","volume":"56","author":"A Saija","year":"1995","unstructured":"Saija A, Princi P, Lanza M, Scalese M, Aramnejad E, De Sarro A. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci. 1995;56:775\u201384.","journal-title":"Life Sci"},{"key":"5062_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature11245","volume":"489","author":"MB Gerstein","year":"2012","unstructured":"Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, et al. Architecture of the human regulatory network derived from ENCODE data. Nature. 2012;489:91\u2013100.","journal-title":"Nature"},{"key":"5062_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.26599\/JNR.2020.9040018","volume":"8","author":"XY Wang","year":"2020","unstructured":"Wang XY, Sun N, Meng XQ, Chen M, Jiang CL, Cai JQ. Review of clinical nerve repair strategies for neurorestoration of central nervous system tumor damage. J Neurorestoratology. 2020;8:172\u201381.","journal-title":"J Neurorestoratology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05062-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T04:14:19Z","timestamp":1727756059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["5062"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05062-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal procedures were approved via the Institutional Animal Care and Use Committee of Harbin Medical University and were processed in accordance with the guideline of Animal Care and Use Committee of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"699"}}